FisherVista

FisherVista

@fishervista

25608 articles
Extend your brand profile by curating daily news.

Articles

Authentic Holdings' Subsidiary Maybacks Global Launches Ring of Combat on Swerve TV to Record Viewership

Authentic Holdings' Subsidiary Maybacks Global Launches Ring of Combat on Swerve TV to Record Viewership

The recent licensing agreement between Maybacks Global Entertainment, LLC, a subsidiary of Authentic Holdings (OTC: AHRO), and Swerve TV has culminated in the successful broadcast of 'Ring of Combat' from the Tropicana in Atlantic City. This event, which took place on June 13, not only exceeded expectations in terms of view...
SFAA Elects New Leadership and Charts Future Course at 117th Annual Meeting

SFAA Elects New Leadership and Charts Future Course at 117th Annual Meeting

The Surety & Fidelity Association of America (SFAA) recently concluded its 117th Annual Meeting, a pivotal event that not only celebrated the achievements within the surety and fidelity industry but also set the stage for its future direction. Under the leadership of SFAA Chair Mike Keimig and SFAA President & CEO Ryan Work...
Aegis Capital Corp. Secures $4.3 Million for Stardust Power's Lithium Processing Facility

Aegis Capital Corp. Secures $4.3 Million for Stardust Power's Lithium Processing Facility

The recent completion of a $4.3 million public offering by Aegis Capital Corp. for Stardust Power Inc. underscores the growing importance of lithium in the global push towards renewable energy and electric vehicles. This financial milestone enables Stardust Power to proceed with a Definitive Feasibility Study for its propos...
Telomir Pharmaceuticals' Telomir-1 Shows Promise in Preclinical Progeria Study

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Preclinical Progeria Study

Telomir Pharmaceuticals, a preclinical stage pharmaceutical company, has reported promising results from its latest preclinical studies on Telomir-1, its lead candidate for treating Hutchinson-Gilford Progeria Syndrome (HGPS). This rare pediatric aging disorder accelerates aging in children, leading to premature death. Unli...
Telomir Pharmaceuticals' Telomir-1 Shows Promise in Preclinical Progeria Study

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Preclinical Progeria Study

Telomir Pharmaceuticals, a preclinical stage pharmaceutical company, has reported promising results from its latest preclinical study on Telomir-1, its lead candidate for treating Hutchinson-Gilford Progeria Syndrome (HGPS). The study, conducted by Smart Assays, demonstrated that Telomir-1 not only improved cell viability b...
Food as Medicine: A Promising Approach to Combat Chronic Diseases and Food Insecurity

Food as Medicine: A Promising Approach to Combat Chronic Diseases and Food Insecurity

The concept of 'food is medicine' (FIM) is gaining traction as a viable strategy to address the dual challenges of chronic disease management and food insecurity in the United States. A systematic review conducted by the American Heart Association has shed light on the potential of FIM programs, such as produce prescription...
Quantum BioPharma Ltd. Advances in Brain and Alcohol Health Research with Phase 2 Trial Approval

Quantum BioPharma Ltd. Advances in Brain and Alcohol Health Research with Phase 2 Trial Approval

Quantum BioPharma Ltd. (NASDAQ: QNTM) is making headlines with its latest advancements in the biopharmaceutical sector, particularly in the realms of brain disorders and alcohol health. The company has recently secured human ethics approval for a Phase 2 trial of FSD202, a promising compound aimed at treating patients with ...
Psyence Biomedical Ltd. to Showcase Ethical Business Practices at Psychedelic Science 2025

Psyence Biomedical Ltd. to Showcase Ethical Business Practices at Psychedelic Science 2025

The selection of Mary-Elizabeth Gifford, Chief of Global Impact at Psyence Biomedical Ltd. (NASDAQ: PBM), as a featured speaker at Psychedelic Science 2025 underscores the growing intersection between psychedelic research and ethical business practices. This event, recognized as the largest international gathering focused o...
PolyPid's Breakthrough in Surgical Infection Prevention Nears FDA Approval

PolyPid's Breakthrough in Surgical Infection Prevention Nears FDA Approval

PolyPid Ltd., a biotech company listed on NASDAQ under the ticker PYPD, has recently announced a pivotal advancement in its quest to combat surgical site infections (SSIs) through its innovative D-PLEX₁₀₀ technology. Following a successful SHIELD II Phase 3 trial, the company secured $26.7 million in funding, extending its ...
SolarBank Corporation Embraces Bitcoin Treasury Strategy to Merge Renewable Energy with Cryptocurrency Investment

SolarBank Corporation Embraces Bitcoin Treasury Strategy to Merge Renewable Energy with Cryptocurrency Investment

SolarBank Corporation, a leader in renewable and clean energy projects across Canada and the U.S., has announced its decision to incorporate bitcoin into its treasury reserves. This strategic move positions SolarBank among the vanguard of public companies adopting cryptocurrency as part of their financial strategy, signalin...
New Report Urges Retailers to Act Now on Tariff Impacts to Avoid Future Financial Strain

New Report Urges Retailers to Act Now on Tariff Impacts to Avoid Future Financial Strain

The global retail sector stands at a critical juncture as shifting trade policies and economic pressures demand immediate and strategic responses from companies. A new report from Alvarez & Marsal's Consumer and Retail Group, titled 'Tariffs & Turmoil – Never Let a Good Crisis Go To Waste,' serves as a clarion call for reta...
LezDo TechMed Revolutionizes Medical Record Review Billing with CaseDrive

LezDo TechMed Revolutionizes Medical Record Review Billing with CaseDrive

LezDo TechMed has taken a significant step forward in the medical record review industry with the launch of CaseDrive, a next-generation billing system designed to streamline the invoicing process for its clients. This innovative platform promises to eliminate common billing issues such as hidden fees, confusing invoices, a...
Intelligent Bio Solutions Inc. to Implement Fingerprint Drug Testing System in Australia

Intelligent Bio Solutions Inc. to Implement Fingerprint Drug Testing System in Australia

The deployment of Intelligent Bio Solutions Inc.'s (NASDAQ: INBS) fingerprint drug screening system by Managed Waste Service (MWS) across its operations in New South Wales represents a pivotal shift in workplace drug testing methodologies. This system, which analyzes fingerprint sweat for drug traces, offers a non-invasive,...
Soligenix's SGX302 Offers New Hope for Psoriasis Patients with Promising Phase 2a Results

Soligenix's SGX302 Offers New Hope for Psoriasis Patients with Promising Phase 2a Results

Psoriasis, a chronic autoimmune disorder affecting more than 7.5 million adults in the United States, presents not only physical discomfort but also emotional distress for those living with the condition. Soligenix Inc. (NASDAQ: SNGX) is making strides in addressing this challenge with its proprietary therapy, SGX302, which...
LezDo TechMed Revolutionizes Medical Record Review Billing with CaseDrive

LezDo TechMed Revolutionizes Medical Record Review Billing with CaseDrive

The medical record review industry is undergoing a significant transformation with the introduction of CaseDrive by LezDo TechMed. This innovative platform is set to redefine the billing process for medical record review services, offering unprecedented transparency and flexibility to clients. The launch of CaseDrive comes ...
HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology

HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology

HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, further cementing its role as a pioneer in the field of digital cardiac care. These patents cover the company's groundbreaking 3D ECG device and a sophisticated rhythm analysis algorithm, both designed to revolutionize how cardiac conditions are d...
HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology

HeartBeam Inc. Advances Cardiac Care with New Patents for 3D ECG Technology

HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, further cementing its role as a pioneer in the field of digital cardiac care. These patents cover the company's groundbreaking 3D ECG device and a sophisticated rhythm analysis algorithm, both designed to revolutionize how cardiac conditions are d...
California Approves World's Largest Battery Energy Storage Project to Accelerate Clean Energy Transition

California Approves World's Largest Battery Energy Storage Project to Accelerate Clean Energy Transition

The California Energy Commission's approval of the Darden Clean Energy Project represents a pivotal moment in the state's ambitious clean energy agenda. As the largest battery energy storage system (BESS) in the world, this project underscores California's leadership in combating climate change and transitioning to renewabl...
Trump's Override of California's EV Mandate Impacts Automakers and Environmental Goals

Trump's Override of California's EV Mandate Impacts Automakers and Environmental Goals

President Donald Trump has taken a decisive step by signing a measure that overrides California's ambitious electric vehicle (EV) mandate, a move that not only challenges the state's authority to set its own environmental standards but also marks a significant setback for the automotive industry's shift towards electrificat...
Platinum Group Metals Ltd. Advances Waterberg Project as Platinum Market Faces Third Year of Deficits

Platinum Group Metals Ltd. Advances Waterberg Project as Platinum Market Faces Third Year of Deficits

The global platinum market is currently navigating through its third consecutive year of substantial supply deficits, a situation that has significant implications for industries reliant on this precious metal. According to the World Platinum Investment Council, the deficit reached approximately 992,000 ounces in 2024, with...
Nutriband Inc. Advances Aversa Fentanyl Towards Commercialization with Kindeva

Nutriband Inc. Advances Aversa Fentanyl Towards Commercialization with Kindeva

The collaboration between Nutriband Inc. (NASDAQ: NTRB) and Kindeva has reached a pivotal milestone with the successful scale-up of the commercial manufacturing process for Aversa Fentanyl. This development is a critical step forward in the fight against opioid abuse, leveraging Nutriband's AVERSA technology to create the w...

Showing 15604-15624 of 25608 articles (Page 744 of 1220)